ZIPSOR (Depomed, Inc.)
Welcome to the PulseAid listing for the ZIPSOR drug offered from Depomed, Inc.. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Depomed, Inc. |
NON-PROPRIETARY NAME: | diclofenac potassium |
SUBSTANCE NAME: | DICLOFENAC POTASSIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, LIQUID FILLED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-06-16 |
END MARKETING DATE: | 0000-00-00 |
ZIPSOR HUMAN PRESCRIPTION DRUG Details:
Item Description | ZIPSOR from Depomed, Inc. |
LABELER NAME: | Depomed, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2009-06-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 13913-008_3e719282-5d4f-4188-bfca-5270d0e1cd55 |
PRODUCT NDC: | 13913-008 |
APPLICATION NUMBER: | NDA022202 |
Other DICLOFENAC POTASSIUM Pharmaceutical Manufacturers / Labelers: